Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Colorectal Neoplasms 5Colonic Neoplasms 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Neurotoxicity Syndromes 3Lung Neoplasms 3Hematologic Neoplasms 3Fatigue 3Small Cell Lung Carcinoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Pain 2Lymphoma 2Leukemia 2Head and Neck Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Testicular Neoplasms 1Teratoma, Ovarian 1Sexuality 1Seizures 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Ototoxicity 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Neurocognitive Disorders 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1

Interventions

Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Dysgerminoma × Mental Status and Dementia Tests × Clear all
NCT01080521 2018-04-12

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

GOG Foundation

Completed
247 enrolled
Gynecologic

Teratoma, Ovarian, Brenner Tumor, Dysgerminoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡